Resmed (RMD) Current Deferred Revenue (2010 - 2026)
Resmed posted quarterly Current Deferred Revenue of $179.3 million for Q1 2026, up 11.74% year-on-year from $160.4 million in Q1 2025, and up 1.83% on a QoQ basis from $176.0 million in Q4 2025.
Resmed (RMD) has 17 years of Current Deferred Revenue data on file, last reported at $179.3 million in Q1 2026.
- For the quarter ending Q1 2026, Current Deferred Revenue rose 11.74% year-over-year to $179.3 million; the trailing twelve-month figure through Mar 2026 stood at $179.3 million (up 11.74% YoY), and the FY2025 full-year result was $166.0 million, up 8.83% from the prior year.
- Current Deferred Revenue for Q1 2026 stood at $179.3 million, up from $176.0 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $179.3 million in Q1 2026 and bottomed at $108.2 million in Q3 2022.
- The 5-year median for Current Deferred Revenue is $150.8 million (2024), against an average of $147.3 million.
- The widest annual swing landed in 2022, when Current Deferred Revenue fell 3.85%; it then surged 35.61% in 2023.
- A 5-year view of Current Deferred Revenue shows it stood at $133.9 million in 2022, then climbed by 11.19% to $148.9 million in 2023, then increased by 5.11% to $156.5 million in 2024, then rose by 12.49% to $176.0 million in 2025, then increased by 1.83% to $179.3 million in 2026.
- The last three Current Deferred Revenue figures came in at $179.3 million (Q1 2026), $176.0 million (Q4 2025), and $167.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Repligen | 6.39 Bn | 5.41 Bn | 108.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 179.28 Mn |
| Dec 31, 2025 | 176.05 Mn |
| Sep 30, 2025 | 167.78 Mn |
| Jun 30, 2025 | 166.03 Mn |
| Mar 31, 2025 | 160.45 Mn |
| Dec 31, 2024 | 156.51 Mn |
| Sep 30, 2024 | 157.19 Mn |
| Jun 30, 2024 | 152.55 Mn |
| Mar 31, 2024 | 150.75 Mn |
| Dec 31, 2023 | 148.90 Mn |
| Sep 30, 2023 | 146.72 Mn |
| Jun 30, 2023 | 138.07 Mn |
| Mar 31, 2023 | 141.04 Mn |
| Dec 31, 2022 | 133.91 Mn |
| Sep 30, 2022 | 108.20 Mn |
| Jun 30, 2022 | 108.67 Mn |
| Mar 31, 2022 | 112.45 Mn |
| Dec 31, 2021 | 111.65 Mn |
| Sep 30, 2021 | 112.53 Mn |
| Jun 30, 2021 | 109.61 Mn |
| Mar 31, 2021 | 105.34 Mn |
| Dec 31, 2020 | 105.24 Mn |
| Sep 30, 2020 | 102.04 Mn |
| Jun 30, 2020 | 98.62 Mn |
| Mar 31, 2020 | 97.11 Mn |
| Dec 31, 2019 | 92.95 Mn |
| Sep 30, 2019 | 86.95 Mn |
| Jun 30, 2019 | 88.67 Mn |
| Mar 31, 2019 | 82.29 Mn |
| Dec 31, 2018 | 72.69 Mn |
| Sep 30, 2018 | 64.82 Mn |
| Jun 30, 2018 | 60.83 Mn |
| Mar 31, 2018 | 58.00 Mn |
| Dec 31, 2017 | 53.28 Mn |
| Sep 30, 2017 | 53.29 Mn |
| Jun 30, 2017 | 51.92 Mn |
| Mar 31, 2017 | 48.68 Mn |
| Dec 31, 2016 | 46.39 Mn |
| Sep 30, 2016 | 47.67 Mn |
| Jun 30, 2016 | 50.01 Mn |
| Mar 31, 2016 | 38.48 Mn |
| Dec 31, 2015 | 36.10 Mn |
| Sep 30, 2015 | 34.85 Mn |
| Jun 30, 2015 | 36.10 Mn |
| Mar 31, 2015 | 37.30 Mn |
| Dec 31, 2014 | 36.88 Mn |
| Sep 30, 2014 | 39.54 Mn |
| Jun 30, 2014 | 42.37 Mn |
| Mar 31, 2014 | 42.18 Mn |
| Dec 31, 2013 | 42.65 Mn |
| Sep 30, 2013 | 43.91 Mn |
| Jun 30, 2013 | 44.95 Mn |
| Mar 31, 2013 | 44.17 Mn |
| Dec 31, 2012 | 43.78 Mn |
| Sep 30, 2012 | 42.98 Mn |
| Jun 30, 2012 | 41.56 Mn |
| Mar 31, 2012 | 43.73 Mn |
| Dec 31, 2011 | 41.84 Mn |
| Sep 30, 2011 | 41.92 Mn |
| Jun 30, 2011 | 45.13 Mn |
| Mar 31, 2011 | 42.13 Mn |
| Dec 31, 2010 | 37.03 Mn |
| Sep 30, 2010 | 35.46 Mn |
| Jun 30, 2010 | 29.51 Mn |